Profile data is unavailable for this security.
About the company
JSP Pharmaceutical Manufacturing (Thailand) PCL is a Thailand-based company, which manufactures and distributes conventional medicines. The Company manufactures and distributes products under customer’s brand name (OEM), as well as under the Company’s brand name. The Company develops, manufactures and sells conventional and traditional medicines, herbal products and dietary supplements, providing a range of services covering the manufacturer and the seller of the products under both customers’ trademark (OEM) and the seller of the products under the Company’s trademark (Own Brand). The Company develops herbal products, dietary supplements with natural extracts and plant-based protein under brand name Supap Osot, and dietary supplements such as using new raw materials or having new production process for both beauty and health under brand name EVITON. The Company’s subsidiary, Caresutic Co., Ltd., is engaged in manufacturing and distribution of dietary supplements and cosmetic products.
- Revenue in THB (TTM)575.58m
- Net income in THB-1.27m
- Incorporated2018
- Employees340.00
- LocationJSP Pharmaceutical Manufacturing (Thailand) PCL255257 Soi. Sathupradit 58,, Bangpongpang,BANGKOK 10120ThailandTHA
- Phone+66 22841218
- Fax+66 22940705
- Websitehttps://www.jsppharma.com/th/
Mergers & acquisitions
| Acquired company | JSP:SET since announced | Transaction value |
|---|---|---|
| Grace Water Med Co Ltd | -35.09% | 1.29m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immuno-Biological Laboratories Co., Ltd. | 188.09m | -45.99m | 1.04bn | 60.00 | -- | 3.95 | -- | 5.51 | -20.69 | -20.69 | 84.62 | 118.02 | 0.5144 | 0.8788 | 3.78 | 13,135,280.00 | -12.58 | -15.11 | -14.85 | -17.61 | 62.06 | 56.66 | -24.45 | -50.04 | 3.49 | 0.494 | 0.1774 | -- | 22.71 | 0.9405 | -11.97 | -- | -- | -- |
| Renascience Inc | 45.66m | -79.15m | 1.05bn | 3.00 | -- | 2.67 | -- | 22.92 | -26.09 | -26.09 | 15.05 | 129.22 | 0.0851 | -- | -- | 63,772,000.00 | -14.74 | -- | -15.49 | -- | 85.75 | -- | -173.36 | -- | -- | -- | 0.1782 | -- | -27.84 | -- | -32.05 | -- | -- | -- |
| JSP Pharmactcl Mnfctrng (Thailand) PCL | 575.58m | -1.27m | 1.05bn | 340.00 | 1,865.55 | 1.21 | 14.06 | 1.83 | 0.0012 | 0.0012 | 1.17 | 1.83 | 0.45 | 4.28 | 7.17 | -- | 2.21 | 2.21 | 2.58 | 2.76 | 25.10 | 29.81 | 4.91 | 4.24 | 0.7365 | -- | 0.2379 | -- | 34.34 | 10.53 | 92.74 | -- | 26.55 | -- |
| Jack Chia Industries Thailand PCL | 885.75m | 95.13m | 1.06bn | 136.00 | 11.14 | 0.787 | 9.25 | 1.20 | 7.05 | 7.05 | 65.61 | 99.74 | 0.5585 | 2.17 | 4.24 | 6,512,870.00 | 6.00 | 5.61 | 6.66 | 6.08 | 41.31 | 41.15 | 10.74 | 10.15 | 4.00 | -- | 0.00 | 64.50 | 18.30 | 1.51 | 7.59 | 1.19 | -9.91 | 0.237 |
